ARS Pharmaceuticals, Inc. short interest in 2025
In 2025, ARS Pharmaceuticals, Inc.'s disclosed short interest ran from 15.24% of shares outstanding on 15 Jan 2025 to 20.75% on 31 Dec 2025, a change of +5.51 percentage points. The year's high was 21.95% on 30 Sep 2025 and its low 15.10% on 31 Jan 2025, averaging 18.50% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 17.77 days on 13 Jun 2025. Full history: ARS Pharmaceuticals, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 15.24% (15 Jan 2025)
- End of year
- 20.75% (31 Dec 2025)
- Change
- +5.51 pp
- High
- 21.95% (30 Sep 2025)
- Low
- 15.10% (31 Jan 2025)
- Average
- 18.50%
- Highest days to cover
- 17.77 (13 Jun 2025)
- SEC filings marked
- 9
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 15.24% | 10.73 | results (8-K) |
| 31 Jan 2025 | 15.10% | 10.44 | |
| 14 Feb 2025 | 16.96% | 14.24 | |
| 28 Feb 2025 | 19.55% | 15.25 | |
| 14 Mar 2025 | 19.99% | 14.73 | |
| 31 Mar 2025 | 17.48% | 6.54 | 10-K filed, results (8-K) |
| 15 Apr 2025 | 16.78% | 8.15 | |
| 30 Apr 2025 | 17.05% | 13.42 | |
| 15 May 2025 | 18.58% | 12.46 | 10-Q filed, results (8-K) |
| 30 May 2025 | 17.46% | 11.38 | |
| 13 Jun 2025 | 16.89% | 17.77 | |
| 30 Jun 2025 | 16.09% | 7.93 | |
| 15 Jul 2025 | 15.15% | 11.88 | |
| 31 Jul 2025 | 15.63% | 11.87 | |
| 15 Aug 2025 | 17.98% | 9.54 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 21.29% | 8.09 | |
| 15 Sep 2025 | 21.84% | 6.10 | |
| 30 Sep 2025 | 21.95% | 8.39 | |
| 15 Oct 2025 | 19.19% | 7.27 | |
| 31 Oct 2025 | 19.99% | 11.89 | |
| 14 Nov 2025 | 20.37% | 8.37 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 20.91% | 8.01 | |
| 15 Dec 2025 | 21.84% | 12.42 | |
| 31 Dec 2025 | 20.75% | 14.71 |
See also: ARS Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.